Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China

Fig. 1

Univariate and multifactorial analysis of Cox regression models for DFS (A) and OS (B) in patients with HCC undergoing hepatectomy after PSM; Kaplan-Meier analysis of DFS (C) and OS (D) for patients with HCC who received adjuvant TACE or not; Kaplan-Meier analysis of DFS (E) and OS (F) for patients with different CNLC stages. DFS, Disease-free survival; OS, Overall survival; HCC, Hepatocellular carcinoma; PSM, Propensity score matching; TACE, Transarterial chemoembolization; CNLC, Chinese liver cancer; HR, Hazard ratio; Cl, Confidence interval; AFP, Alpha-fetoprotein; ALT, Alanine aminotransferase; AST, Aspartate aminotransferase; GGT, Gamma-glutamyltransferase; ALP, Alkaline phosphatase; TB, Total bilirubin; WBC, White blood cell; CR, Creatinine; PT, Prothrombin time; NLR, Neutrophil-to-lymphocyte ratio; LMR, Lymphocyte-to-monocyte ratio; PLR, Platelet-to-lymphocyte ratio; HBV, Hepatitis B virus; MVI, Microvascular invasion

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us